Published in Surgery on September 01, 1992
A comparison of fine-needle aspiration, core biopsy, and surgical biopsy in the diagnosis of extremity soft tissue masses. Clin Orthop Relat Res (2010) 1.22
Pediatric soft tissue sarcomas. Surg Clin North Am (2008) 1.21
Biopsy of soft tissue masses: evidence-based medicine for the musculoskeletal tumor society. Clin Orthop Relat Res (2009) 1.19
Image-guided percutaneous biopsy of musculoskeletal lesions in children. Pediatr Radiol (2007) 1.04
Fine needle aspiration for clinical triage of extremity soft tissue masses. Clin Orthop Relat Res (2009) 1.03
Orthopaedic . Radiology . Pathology Conference: Painful distal femur Lesion in a 13-year-old girl. Clin Orthop Relat Res (2008) 0.78
Predictors of diagnostic success in image-guided pediatric soft-tissue biopsies. Pediatr Radiol (2015) 0.75
Role of fine-needle aspiration cytology and core needle biopsy in diagnosing musculoskeletal neoplasms. J Cytol (2016) 0.75
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med (1998) 11.03
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med (1988) 8.90
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. J Natl Cancer Inst (1994) 7.20
Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med (1991) 7.17
Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA (1994) 6.36
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother (2001) 5.83
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol (1998) 5.74
Global iron connections between desert dust, ocean biogeochemistry, and climate. Science (2005) 5.63
Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med (1990) 5.27
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene (2000) 4.90
The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO J (2000) 4.82
Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response. Ann Surg (1998) 4.35
GALEN ten years on: tasks and supporting tools. Stud Health Technol Inform (2001) 4.34
Sound- and/or pressure-induced vertigo due to bone dehiscence of the superior semicircular canal. Arch Otolaryngol Head Neck Surg (1998) 4.18
Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J Immunol (1989) 3.60
Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg (1989) 3.58
The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med (1986) 3.27
Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J Immunol Methods (1987) 3.09
Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J Exp Med (1997) 3.07
High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. J Immunol (1999) 2.94
Impacts of atmospheric anthropogenic nitrogen on the open ocean. Science (2008) 2.85
BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet (2008) 2.79
Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat Med (1995) 2.74
[Toxic hepatitis caused by droxicam]. Med Clin (Barc) (1992) 2.69
Isolation of a Helicobacter pylori protein, FldA, associated with mucosa-associated lymphoid tissue lymphoma of the stomach. Gastroenterology (1999) 2.63
The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health (1995) 2.43
Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens. J Natl Cancer Inst (1998) 2.17
The large subunit of RNA polymerase II is a substrate of the Rsp5 ubiquitin-protein ligase. Proc Natl Acad Sci U S A (1997) 2.09
Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol (1995) 2.02
Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J Clin Oncol (1989) 2.00
Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2. J Immunol (1987) 1.96
Lethal injuries and time to death in a level I trauma center. J Am Coll Surg (1998) 1.94
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst (1993) 1.91
Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma. Cancer J Sci Am (2006) 1.89
Management of symptomatic malignant melanoma of the gastrointestinal tract. Ann Surg Oncol (1999) 1.88
Increases in manic symptoms after life events involving goal attainment. J Abnorm Psychol (2000) 1.85
Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet (2005) 1.85
The diposi tion of morphine in surgical patients. Clin Pharmacol Ther (1975) 1.83
Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol (1990) 1.82
Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b. J Clin Oncol (1999) 1.78
Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med (1988) 1.78
In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. Cancer Res (1995) 1.76
Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas. Cancer Res (2001) 1.74
The future need for geriatric manpower in the United States. N Engl J Med (1980) 1.72
Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine. J Immunol (1999) 1.71
Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy. Cancer J Sci Am (1998) 1.68
Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol (2001) 1.59
A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy. J Clin Oncol (1990) 1.59
Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma. Mod Pathol (2000) 1.59
Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530. Oncogene (2008) 1.57
Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res (1995) 1.57
Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Interventions Trial. N Engl J Med (1997) 1.55
Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential. Int J Gynecol Pathol (1998) 1.54
Management of acute cholangitis and the impact of endoscopic sphincterotomy. Br J Surg (1986) 1.53
Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma. Int J Radiat Oncol Biol Phys (1991) 1.53
Intracystic papillary carcinoma of the breast. After mastectomy, radiotherapy or excisional biopsy alone. Cancer (1983) 1.53
Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res (1992) 1.52
Percutaneous trans-hepatic cholangioscopy and lithotripsy in the treatment of intrahepatic stones: a study with 5 year follow-up. Gastrointest Endosc (1995) 1.50
The cycling of organic nitrogen through the atmosphere. Philos Trans R Soc Lond B Biol Sci (2013) 1.49
A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapy. J Immunother Emphasis Tumor Immunol (1994) 1.49
Accurate diagnosis of Helicobacter pylori infection by stool antigen test and 6 other currently available tests in children. J Pediatr (2000) 1.49
The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma. J Clin Oncol (1992) 1.48
Malignant lymphomas involving the ovary. A clinicopathologic analysis of 39 cases. Am J Surg Pathol (1993) 1.48
Incidence of venous air embolism during cesarean section is unchanged by the use of a 5 to 10 degree head-up tilt. Anesth Analg (1989) 1.47
Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100. J Immunother (1997) 1.47
In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma. J Natl Cancer Inst (1989) 1.46
Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. J Clin Oncol (1988) 1.46
Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer. J Clin Oncol (1989) 1.46
Papillary endothelial hyperplasia in the thyroid following fine-needle aspiration. Arch Pathol Lab Med (1991) 1.46
Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer. Hum Pathol (1994) 1.45
Lithium discontinuation and subsequent effectiveness. Am J Psychiatry (1998) 1.45
Transient torsion during and after saccades. Vision Res (1995) 1.45
Pancreatic tuberculosis with obstructive jaundice--a case report. Am J Gastroenterol (1999) 1.44
Identical genetic changes in different histologic components of Wilms' tumors. J Natl Cancer Inst (1997) 1.44
Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr (1993) 1.43
Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol (1995) 1.43
Signet ring carcinoma of the female breast: a clinicopathologic analysis of 24 cases. Cancer (1981) 1.42
Utilization of microdissection and the polymerase chain reaction for the diagnosis of adrenal cortical carcinoma in fine-needle aspiration cytology. Cancer (1999) 1.39
Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res (1991) 1.38
Cyclodeviation in skew deviation. Am J Ophthalmol (1994) 1.38
Solution to the dilemma of retrieving an endoscope from the esophagus. Gastrointest Endosc (1999) 1.38
Bone densitometry--role of quantitative computed tomography. S Afr Med J (2002) 1.38
Guidelines for specimen adequacy--a plea for workable definitions. Diagn Cytopathol (1991) 1.38
Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol (1993) 1.37
Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma. Hum Pathol (1999) 1.37
Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas. J Natl Cancer Inst (1997) 1.35
Cytologic detection of esophageal squamous cell carcinoma and precursor lesions using balloon and sponge samplers in asymptomatic adults in Linxian, China. Cancer (1997) 1.35
Treatment of hirsutism with spironolactone. JAMA (1982) 1.34
Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes. J Immunol (1990) 1.33
Scintigraphic findings and follow up in Erdheim-Chester disease. Eur J Nucl Med (1990) 1.33
Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry (1996) 1.33
Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch Ophthalmol (1997) 1.32
Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med (1990) 1.31
In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2. J Natl Cancer Inst (1987) 1.31
Choledochoduodenostomy, transduodenal sphincteroplasty and sphincterotomy for calculi of the common bile duct. Surg Gynecol Obstet (1987) 1.29
Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action. Anesthesiology (1976) 1.26